EFFECT OF D-AMPHETAMINE AND L-AMPHETAMINE ON RAT PLASMA PROLACTIN LEVELS

被引:20
作者
MELTZER, HY
FESSLER, RG
SIMONOVIC, M
DOHERTY, J
FANG, VS
机构
[1] UNIV CHICAGO, PRITZKER SCH MED, DEPT PHARMACOL & PHYSIOL SCI, CHICAGO, IL 60637 USA
[2] UNIV CHICAGO, PRITZKER SCH MED, DEPT MED, CHICAGO, IL 60637 USA
[3] ILLINOIS STATE PSYCHIAT INST, CHICAGO, IL 60612 USA
关键词
5-Hydroxytryptophan; Alpha-methylparatyrosine; d-Amphetamine; Dopamine; l-Amphetamine; Prolactin; Reserpine; Supersensitivity; Tolerance;
D O I
10.1007/BF00426812
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Although d- and l-amphetamine had no effect on plasma prolactin levels in untreated male rats, both d- and l-amphetamine reversed the increase in plasma prolactin levels produced by reserpine and 5-hydroxytryptophan (5-HTP). Only d-amphetamine significantly reversed the effect of alpha-methylparatyrosine (AMPT) on plasma prolactin levels. This reversal is probably due to a direct or indirect dopamine agonist effect of amphetamine, rather than to an effect on norepinephrine. This conclusion is based on the finding that apomorphine, a direct-acting dopamine agonist, reversed the reserpine-induced increase in prolactin secretion, while clonidine, a direct-acting alpha-adrenergic agonist, potentiated the reserpine-induced stimulation of prolactin secretion. The effect of d-amphetamine on the increase in plasma prolactin levels produced by reserpine, 5-HTP, or AMPT was always greater than that of the l-isomer, suggesting that the d-isomer has a more profound effect on dopaminerelease or neuronal reuptake, or both, than l-amphetamine. Chronic administration of d-amphetamine prior to reserpine did not inhibit the ability of d-amphetamine to reverse the reserpine-induced increase in plasma prolactin. Chronic administration of AMPT did not enhance the ability of d-amphetamine to reverse the AMPT-induced increase in plasma prolactin. © 1979 Springer-Verlag.
引用
收藏
页码:63 / 69
页数:7
相关论文
共 53 条
[31]  
MELTZER HY, 1976, PSYCHOPHARMACOL COMM, V2, P189
[32]  
MELTZER HY, 1977, NEUR ABS, V3, P351
[33]  
MELTZER HY, 1978, PSYCHOPHARMACOLOGY G, P509
[34]   D-AMPHETAMINE AS A RELEASER OR REUPTAKE INHIBITOR OF BIOGENIC-AMINES IN SYNAPTOSOMES [J].
RAITERI, M ;
BERTOLLINI, A ;
ANGELINI, F ;
LEVI, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1975, 34 (01) :189-195
[35]   EFFECTS OF AMPHETAMINE, METHYLPHENIDATE AND COCAINE ON SERUM PROLACTIN CONCENTRATIONS IN MALE RAT [J].
RAVITZ, AJ ;
MOORE, KE .
LIFE SCIENCES, 1977, 21 (02) :267-272
[36]  
RECH RH, 1968, J PHARMACOL EXP THER, V160, P326
[37]   POTENTIATION BY RESERPINE OF INHIBITION BY AMPHETAMINE OF [DOPAMINE-H-3] ACCUMULATION IN RAT STRIATUM [J].
ROSS, SB .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1977, 29 (07) :433-434
[38]  
RUTLEDGE CO, 1973, FRONTIERS CATECHOLAM, P973
[40]   EVIDENCE FOR A PRIME ROLE OF NEWLY SYNTHESIZED DOPAMINE IN MESOLIMBIC DOPAMINE AREAS [J].
SEARS, ES ;
SHORE, PA .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1975, 27 (09) :718-720